Clinical trial
Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening
NCT04746872 is registered in ClinicalTrials.gov with Abbott Molecular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening
- Lead sponsor
- Abbott Molecular
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 16, 2021
- Completion date
- November 3, 2022
- Enrollment
- 14,935 (actual)
- Sites
- 63
Conditions
As the registry lists them; a condition with its own page is linked.
human papillomavirus